Marty Makary will face a vote before the Senate Health, Education, Labor, and Pensions Committee today, 13th March. If approved, he will be a significant step closer to taking up his nominated position as head of the US Food and Drug Administration (FDA).
A full Senate vote is not yet scheduled, but gaining committee approval is a major positive for nominees. There has only been one nominee approved by the full Senate after failing to gain a recommendation by the relevant Senate committee in more than half a century. What that could mean to the nicotine alternatives industry likely very much depends on general outlook.